Sayenko Kharenko had advised Horizon Capital on the sale by its Emerging Europe Growth Fund III, LP of a minority stake in Dobrobut to the company's existing shareholders: Dobrobut Managing Shareholder and CEO Oleg Kalashnikov, and Concorde Capital. Avellum advised the shareholders on the deal.
Horizon Capital is backed by over 40 institutional investors with a capital base of over USD 350 billion, managing four funds with assets under management of over USD 850 million and a tenure of 25 years in the region.
According to Avellum, "Dobrobut is the leading private healthcare services provider in Ukraine with a network of clinics and medical institutions in Kyiv and Kyiv region, offering high-quality, essential services to patients in Ukraine. As one of the most innovative players in the industry, Dobrobut continuously invests in the digitalization of business processes, including a mobile platform that allows patients to plan and pay for their visits online."
Both Sayenko Kharenko and Avellum worked on Horizon Capital's acquisition of the stake it now sells back to the shareholders in 2019 (as reported by CEE Legal Matters on May 27, 2019).
Sayenko Kharenko Partner Alina Plyushch described the buyback by the shareholders as "a landmark project for Ukrainian private medical services market." According to her, "I am convinced that it is hard to overestimate the importance of investing in medical sector today, when Ukraine is struggling with a pandemic."
Plyushch supervised Sayenko Kharenko’s team working on the deal, which was managed by Senior Associate Dmitriy Riabikin, supported by Associate Yaroslava Chernyshchuk.
Avellum's team was supervised by Partner Yuriy Nechayev and led by Senior Associate Anton Arkhypov, with support from Associate Andriy Kornuta.